Data as of Dec 19
| -2.55 / -1.80%|
The 30 analysts offering 12-month price forecasts for Bayer have a median target of 154.38, with a high estimate of 172.16 and a low estimate of 113.59. The median estimate represents a +10.80% increase from the last price of 139.34.
The current consensus among 30 polled investment analysts is to Buy stock in Bayer. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.